Behind Gene Editing’s Big Moment with Sickle-Cell Treatment | WSJ

Описание к видео Behind Gene Editing’s Big Moment with Sickle-Cell Treatment | WSJ

The U.S. has approved the world’s first medicine to treat sickle-cell disease. Executives from the companies that developed the gene-edited treatment—Crispr Therapeutics and Vertex Pharmaceuticals—discuss the breakthrough's potential and risks.

#Biotech #Healthcare #WSJ

Комментарии

Информация по комментариям в разработке